<?xml version="1.0" encoding="UTF-8"?>
<p>Statistical evaluation of the primary and secondary endpoints will be presented for each randomisation stratum (ie, prior treatment with IVIg or corticosteroids) separately. No further subgroup analyses are pre‚Äêspecified. Further comparisons between CIDP variants may be added post hoc as indicated by the data.</p>
